Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH.
Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002; 162:2217-22.
Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL. et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997; 12:1761-8.
Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996; 144:255-63.
Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J. et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004; 19:783-90.
Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E. et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34:195-202.
Lewis CE, Ewing SK, Taylor BC, Shikany JM, Fink HA, Ensrud KE. et al. Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res. 2007; 22:211-9.
Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res. 2002; 17:1051-6.
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J. et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18:1033-46.
MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M. et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008; 148:197-213.
Bateman C. South Africa under-prioritises osteoporosis. S Afr Med J. 2006; 96:19-20.
Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES. et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA. 2007; 298:629-37.
Brunader R, Shelton DK. Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician. 2002; 65:1357-64.
Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C. et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002; 13:527-36.
Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall? JAMA. 2007; 297:77-86.
Chang JT, Morton SC, Rubenstein LZ, Mojica WA, Maglione M, Suttorp MJ. et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ. 2004; 328:680.
Cooper H, Hedges LV. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994.
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3:25.
Hatjimihail AT. Quality of diagnostic accuracy studies: the development, use, and evaluation of QUADAS. Evid Based Med. 2006; 11:189.
Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991; 44:1271-8.
Hanley JA. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging. 1989; 29:307-35.
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S. et al. Grading quality of evidence and strength of recommendations. BMJ. 2004; 328:1490.
Adler RA, Funkhouser HL, Holt CM. Utility of heel ultrasound bone density in men. J Clin Densitom. 2001; 4:225-30.
Adler RA, Funkhouser HL, Petkov VI, Elmore BL, Via PS, McMurtry CT. et al. Osteoporosis in pulmonary clinic patients: does point-of-care screening predict central dual-energy X-ray absorptiometry? Chest. 2003; 123:2012-8.
Adler RA, Tran MT, Petkov VI. Performance of the Osteoporosis Self-assessment Screening Tool for osteoporosis in American men. Mayo Clin Proc. 2003; 78:723-7.
Cheng S, Suominen H, Sakari-Rantala R, Laukkanen P, Avikainen V, Heikkinen E. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. J Bone Miner Res. 1997; 12:1075-82.
De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998; 13:1587-93.
Donaldson MM, McGrother CW, Clayton DG, Clarke M, Osborne D. Calcaneal ultrasound attenuation in an elderly population: measurement position and relationships with body size and past fractures. Osteoporos Int. 1999; 10:316-24.
Gonnelli S, Cepollaro C, Gennari L, Montagnani A, Caffarelli C, Merlotti D. et al. Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men. Osteoporos Int. 2005; 16:963-8.
Grampp S, Henk C, Lu Y, Krestan C, Resch H, Kainberger F. et al. Quantitative US of the calcaneus: cutoff levels for the distinction of healthy and osteoporotic individuals. Radiology. 2001; 220:400-5.
Gudmundsdottir SL, Indridason OS, Franzson L, Sigurdsson G. Age-related decline in bone mass measured by dual-energy X-ray absorptiometry and quantitative ultrasound in a population-based sample of both sexes: identification of useful ultrasound thresholds for osteoporosis screening. J Clin Densitom. 2005; 8:80-6.
Kaptoge S, Armbrecht G, Felsenberg D, Lunt M, O'Neill TW, Silman AJ. et al. When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2004; 19:1982-93.
Karlsson KM, Sernbo I, Obrant KJ, Redlund-Johnell I, Johnell O. Femoral neck geometry and radiographic signs of osteoporosis as predictors of hip fracture. Bone. 1996; 18:327-30.
Kröger H, Lunt M, Reeve J, Dequeker J, Adams JE, Birkenhager JC. et al. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantitation of osteoporosis study. Calcif Tissue Int. 1999; 64:191-9.
Kung AW, Ho AY, Ross PD, Reginster JY. Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness to quantitative bone ultrasound. Osteoporos Int. 2005; 16:849-55.
Li-Yu JT, Llamado LJ, Torralba TP. Validation of OSTA among Filipinos. Osteoporos Int. 2005; 16:1789-93.
Lynn HS, Lau EM, Wong SY, Hong AW. An osteoporosis screening tool for Chinese men. Osteoporos Int. 2005; 16:829-34.
Melton LJ 3rd, Beck TJ, Amin S, Khosla S, Achenbach SJ, Oberg AL. et al. Contributions of bone density and structure to fracture risk assessment in men and women. Osteoporos Int. 2005; 16:460-7.
Montagnani A, Gonnelli S, Cepollaro C, Mangeri M, Monaco R, Gennari L. et al. Usefulness of bone quantitative ultrasound in management of osteoporosis in men. J Clin Densitom. 2001; 4:231-7.
Mulleman D, Legroux-Gerot I, Duquesnoy B, Marchandise X, Delcambre B, Cortet B. Quantitative ultrasound of bone in male osteoporosis. Osteoporos Int. 2002; 13:388-93.
Odvina CV, Wergedal JE, Libanati CR, Schulz EE, Baylink DJ. Relationship between trabecular vertebral body density and fractures: a quantitative definition of spinal osteoporosis. Metabolism. 1988; 37:221-8.
Robinson B, Wagstaffe C, Roche J, Clifton-Bligh P, Posen S. Is there a place for forearm osteodensitometry in clinical screening studies? Med J Aust. 1987; 146:297-300.
Rothenberg RJ, Boyd JL, Holcomb JP. Quantitative ultrasound of the calcaneus as a screening tool to detect osteoporosis: different reference ranges for caucasian women, african american women, and caucasian men. J Clin Densitom. 2004; 7:101-10.
Shin MH, Kweon SS, Park KS, Heo H, Kim SJ, Nam HS. et al. Quantitative ultrasound of the calcaneus in a Korean population: reference data and relationship to bone mineral density determined by peripheral dual X-ray absorptiometry. J Korean Med Sci. 2005; 20:1011-6.
Stewart A, Felsenberg D, Kalidis L, Reid DM. Vertebral fractures in men and women: how discriminative are bone mass measurements? Br J Radiol. 1995; 68:614-20.
Travers-Gustafson D, Stegman MR, Heaney RP, Recker RR. Ultrasound, densitometry, and extraskeletal appendicular fracture risk factors: a cross-sectional report on the Saunders County Bone Quality Study. Calcif Tissue Int. 1995; 57:267-71.
Varenna M, Sinigaglia L, Adami S, Giannini S, Isaia G, Maggi S. et al. Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: the ESOPO study. Osteoporos Int. 2005; 16:1749-54.
Welch A, Camus J, Dalzell N, Oakes S, Reeve J, Khaw KT. Broadband ultrasound attenuation (BUA) of the heel bone and its correlates in men and women in the EPIC-Norfolk cohort: a cross-sectional population-based study. Osteoporos Int. 2004; 15:217-25.
Bauer DC, Cauley JA, Ensrud KE, Ewing S, Orwoll ES. Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study [Abstract]. Presented at the American Society for Bone and Mineral Research 26th Annual Meeting, Seattle, Washington, 1-5 October 2004:1023.
Espallargues M, Sampietro-Colom L, Estrada MD, Solà M, del Rio L, Setoain J. et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int. 2001; 12:811-22.
Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997; 315:841-6.
Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A. et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol. 1998; 147:871-9.
Bakhireva LN, Barrett-Connor E, Kritz-Silverstein D, Morton DJ. Modifiable predictors of bone loss in older men: a prospective study. Am J Prev Med. 2004; 26:436-42.
Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW. et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000; 15:710-20.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Serrano-Arias M, Cannata-Andía JB. Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population. Osteoporos Int. 2005; 16:603-9.
Roy DK, O'Neill TW, Finn JD, Lunt M, Silman AJ, Felsenberg D. et al. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int. 2003; 14:19-26.
Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J. et al. Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int. 1999; 9:45-54.
Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol. 1997; 157:439-44.
Orwoll ES, Bevan L, Phipps KR. Determinants of bone mineral density in older men. Osteoporos Int. 2000; 11:815-21.
Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA. et al. A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int. 2005; 16:799-804.
Praet JP, Peretz A, Rozenberg S, Famaey JP, Bourdoux P. Risk of osteoporosis in men with chronic bronchitis. Osteoporos Int. 1992; 2:257-61.
Kemppainen T, Kröger H, Janatuinen E, Arnala I, Kosma VM, Pikkarainen P. et al. Osteoporosis in adult patients with celiac disease. Bone. 1999; 24:249-55.
Diamond TH, Bucci J, Kersley JH, Aslan P, Lynch WB, Bryant C. Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy. J Urol. 2004; 172:529-32.
Boonen S, Vanderschueren D, Cheng XG, Verbeke G, Dequeker J, Geusens P. et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res. 1997; 12:2119-26.
Glynn NW, Meilahn EN, Charron M, Anderson SJ, Kuller LH, Cauley JA. Determinants of bone mineral density in older men. J Bone Miner Res. 1995; 10:1769-77.
Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ, Skrabal F. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med. 2002; 252:389-97.
Cauley JA, Fullman RL, Stone KL, Zmuda JM, Bauer DC, Barrett-Connor E. et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005; 16:1525-37.
Wong PK, Spencer DG, McElduff P, Manolios N, Larcos G, Howe GB. Secondary screening for osteoporosis in patients admitted with minimal-trauma fracture to a major teaching hospital. Intern Med J. 2003; 33:505-10.
Morris MS, Jacques PF, Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone. 2005; 37:234-42.
Cankurtaran M, Yavuz BB, Halil M, Dagli N, Ariogul S. General characteristics, clinical features and related factors of osteoporosis in a group of elderly Turkish men. Aging Clin Exp Res. 2005; 17:108-15.
Lin JD, Chen JF, Chang HY, Ho C. Evaluation of bone mineral density by quantitative ultrasound of bone in 16, 862 subjects during routine health examination. Br J Radiol. 2001; 74:602-6.
Cohen-Solal ME, Baudoin C, Omouri M, Kuntz D, De Vernejoul MC. Bone mass in middle-aged osteoporotic men and their relatives: familial effect. J Bone Miner Res. 1998; 13:1909-14.
Mitchell BD, Kammerer CM, Schneider JL, Perez R, Bauer RL. Genetic and environmental determinants of bone mineral density in Mexican Americans: results from the San Antonio Family Osteoporosis Study. Bone. 2003; 33:839-46.
Hussain SA, Weston R, Stephenson RN, George E, Parr NJ. Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation. BJU Int. 2003; 92:690-4.
Mallmin H, Ljunghall S, Persson I, Bergström R. Risk factors for fractures of the distal forearm: a population-based case-control study. Osteoporos Int. 1994; 4:298-304.
Diaz MN, O'Neill TW, Silman AJ. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study. Bone. 1997; 20:145-9.
Soroko SB, Barrett-Connor E, Edelstein SL, Kritz-Silverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study. J Bone Miner Res. 1994; 9:761-9.
Elliot JR, Gilchrist NL, Wells JE, Ayling E, Turner J, Sainsbury R. Historical assessment of risk factors in screening for osteopenia in a normal Caucasian population. Aust N Z J Med. 1993; 23:458-62.
Tanaka T, Latorre MR, Jaime PC, Florindo AA, Pippa MG, Zerbini CA. Risk factors for proximal femur osteoporosis in men aged 50 years or older. Osteoporos Int. 2001; 12:942-9.
Shin A, Choi JY, Chung HW, Park SK, Shin CS, Choi YH. et al. Prevalence and risk factors of distal radius and calcaneus bone mineral density in Korean population. Osteoporos Int. 2004; 15:639-44.
Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA. et al. Alcohol intake as a risk factor for fracture. Osteoporos Int. 2005; 16:737-42.
Høidrup S, Grønbaek M, Gottschau A, Lauritzen JB, Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol. 1999; 149:993-1001.
Lau EM, Suriwongpaisal P, Lee JK, Das De S, Festin MR, Saw SM. et al. Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res. 2001; 16:572-80.
Melton LJ 3rd, Achenbach SJ, O'Fallon WM, Khosla S. Secondary osteoporosis and the risk of distal forearm fractures in men and women. Bone. 2002; 31:119-25.
Naves Diaz M, O'Neill TW, Silman AJ. The influence of alcohol consumption on the risk of vertebral deformity. European Vertebral Osteoporosis Study Group. Osteoporos Int. 1997; 7:65-71.
Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc. 1991; 39:766-71.
Kim MJ, Shim MS, Kim MK, Lee Y, Shin YG, Chung CH. et al. Effect of chronic alcohol ingestion on bone mineral density in males without liver cirrhosis. Korean J Intern Med. 2003; 18:174-80.
Wong SY, Lau EM, Lynn H, Leung PC, Woo J, Cummings SR. et al. Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos Int. 2005; 16:610-5.
Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK. et al. Body composition changes with age have gender-specific impacts on bone mineral density. Bone. 2004; 35:792-8.
Izumotani K, Hagiwara S, Izumotani T, Miki T, Morii H, Nishizawa Y. Risk factors for osteoporosis in men. J Bone Miner Metab. 2003; 21:86-90.
Shaw CK. An epidemiologic study of osteoporosis in Taiwan. Ann Epidemiol. 1993; 3:264-71.
Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005; 352:154-64.
Melton LJ 3rd, Alothman KI, Khosla S, Achenbach SJ, Oberg AL, Zincke H. Fracture risk following bilateral orchiectomy. J Urol. 2003; 169:1747-50.
Yaturu S, DjeDjos S, Alferos G, Deprisco C. Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy. Prostate Cancer Prostatic Dis. 2006; 9:35-8.
Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q. et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer. 2004; 101:541-9.
Oefelein MG, Ricchuiti V, Conrad W, Seftel A, Bodner D, Goldman H. et al. Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer. J Urol. 2001; 166:1724-8.
Hatano T, Oishi Y, Furuta A, Iwamuro S, Tashiro K. Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer. BJU Int. 2000; 86:449-52.
Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT. Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol. 2000; 163:181-6.
Stoch SA, Parker RA, Chen L, Bubley G, Ko YJ, Vincelette A. et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab. 2001; 86:2787-91.
López AM, Pena MA, Hernández R, Val F, Martín B, Riancho JA. Fracture risk in patients with prostate cancer on androgen deprivation therapy. Osteoporos Int. 2005; 16:707-11.
Smith MR, Lee WC, Brandman J, Wang Q, Botteman M, Pashos CL. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol. 2005; 23:7897-903.
Chen Z, Maricic M, Nguyen P, Ahmann FR, Bruhn R, Dalkin BL. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma. Cancer. 2002; 95:2136-44.
Cheung EY, Ho AY, Lam KF, Tam S, Kung AW. Determinants of bone mineral density in Chinese men. Osteoporos Int. 2005; 16:1481-6.
Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest. 1999; 116:1616-24.
Maugeri D, Panebianco P, Barbagallo P, Malaguarnera M, Curasi MP, Russo MS. et al. Estrogens and euosteogenesis in men. Eur Rev Med Pharmacol Sci. 1998; 2:189-92.
Laroche M, Moulinier L, Bon E, Cantagrel A, Mazieres B. Renal tubular disorders and arteriopathy of the lower limbs: risk factors for osteoporosis in men? Osteoporos Int. 1994; 4:309-13.
Yeh SS, Phanumas D, Hafner A, Schuster MW. Risk factors for osteoporosis in a subgroup of elderly men in a Veterans Administration nursing home. J Investig Med. 2002; 50:452-7.
Moyad MA. Osteoporosis—Part I: Risk factors and screening. Urol Nurs. 2002; 22:276-9.
Lunt M, Masaryk P, Scheidt-Nave C, Nijs J, Poor G, Pols H. et al. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int. 2001; 12:688-98.
Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA. 1992; 268:3333-7.
Benson BW, Shulman JD. Inclusion of tobacco exposure as a predictive factor for decreased bone mineral content. Nicotine Tob Res. 2005; 7:719-24.
Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE. et al. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005; 20:596-603.
Diamond TH, Thornley SW, Sekel R, Smerdely P. Hip fracture in elderly men: prognostic factors and outcomes. Med J Aust. 1997; 167:412-5.
Heijckmann AC, Huijberts MS, Geusens P, de Vries J, Menheere PP, Wolffenbuttel BH. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma. Eur J Endocrinol. 2005; 153:23-9.
Karadag F, Cildag O, Yurekli Y, Gurgey O. Should COPD patients be routinely evaluated for bone mineral density? J Bone Miner Metab. 2003; 21:242-6.
Villareal MS, Klaustermeyer WB, Hahn TJ, Gordon EH. Osteoporosis in steroid-dependent asthma. Ann Allergy Asthma Immunol. 1996; 76:369-72.
Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003; 114:10-4.
Ohldin A, Floyd J. Unrecognized risks among Veterans with hip fractures: opportunities for improvements. J South Orthop Assoc. 2003; 12:18-22.
von Wowern N, Klausen B, Hylander E. Bone loss and oral state in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1996; 20:105-9.
Jones LM, Legge M, Goulding A. Intensive exercise may preserve bone mass of the upper limbs in spinal cord injured males but does not retard demineralisation of the lower body. Spinal Cord. 2002; 40:230-5.
Sabo D, Blaich S, Wenz W, Hohmann M, Loew M, Gerner HJ. Osteoporosis in patients with paralysis after spinal cord injury. A cross sectional study in 46 male patients with dual-energy X-ray absorptiometry. Arch Orthop Trauma Surg. 2001; 121:75-8.
Demirel G, Yilmaz H, Paker N, Onel S. Osteoporosis after spinal cord injury. Spinal Cord. 1998; 36:822-5.
Lazo MG, Shirazi P, Sam M, Giobbie-Hurder A, Blacconiere MJ, Muppidi M. Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord. 2001; 39:208-14.
Haugeberg G, Ørstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum. 2002; 46:1720-8.
Nayak S, Olkin I, Liu H, Grabe M, Gould MK, Allen IE. et al. Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med. 2006; 144:832-41.
Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS. et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001; 12:519-28.
Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA. et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001; 286:2815-22.
Rud B, Hilden J, Hyldstrup L, Hróbjartsson A. Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review. Osteoporos Int. 2007; 18:1177-87.
Seeman E, Bianchi G, Adami S, Kanis J, Khosla S, Orwoll E. Osteoporosis in men—consensus is premature. Calcif Tissue Int. 2004; 75:120-2.
Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP. et al. A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int. 2001; 12:699-705.
Bauer DC, Ewing SK, Cauley JA, Ensrud KE, Cummings SR, Orwoll ES. et al. Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporos Int. 2007; 18:771-7.
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-47.
Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B. et al. Assessment of fracture risk. Osteoporos Int. 2005; 16:581-9.
Shepherd AJ, Cass AR, Carlson CA, Ray L. Development and internal validation of the male osteoporosis risk estimation score. Ann Fam Med. 2007; 5:540-6.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344:1434-41.
Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC. et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996; 348:1535-41.
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C. et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001; 344:333-40.
Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C. et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002; 87:3609-17.